Germain N, Boichot E, Planquois J M, Lagente V
INSERM U456, Laboratoire de Pharmacodynamie et de Pharmacologie Moléculaire, Faculté des Sciences Pharmaceutiques et Biologiques, Université de Rennes 1, France.
Mediators Inflamm. 1999;8(3):153-7. doi: 10.1080/09629359990487.
The aim of the present study was to compare the effects of selective phosphodiesterase (PDE) 3, 4 and 5 inhibitors on antigen-induced airway hyperresponsiveness in sensitized guinea-pigs. When the sensitized guinea-pigs were orally pre-treated with the selective PDE4 inhibitor, Ro 20-1724 (30 mg/kg), and studied 48h after OA, a significant reduction (P<0.01) of the leftward shift of the dose-response curve to ACh was noted, whereas it was ineffective at the lower dose (10 mg/kg). Administration of the selective PDE3 inhibitor, milrinone (30 mg/kg) also elicited a significant reduction (P<0.01) of the airway hyperresponsiveness, whereas the PDE5 inhibitor zaprinast (30 mg/kg) was ineffective. These results show that both PDE3 and PDE4 inhibitors are able to inhibit the antigen-induced airway hyperresponsiveness in sensitized guinea-pigs and support the potential utility of selective PDE inhibitors in the treatment of asthma.
本研究的目的是比较选择性磷酸二酯酶(PDE)3、4和5抑制剂对致敏豚鼠抗原诱导的气道高反应性的影响。当致敏豚鼠口服选择性PDE4抑制剂Ro 20-1724(30 mg/kg)并在卵清蛋白激发后48小时进行研究时,发现乙酰胆碱剂量反应曲线向左移位显著降低(P<0.01),而在较低剂量(10 mg/kg)时无效。给予选择性PDE3抑制剂米力农(30 mg/kg)也可显著降低(P<0.01)气道高反应性,而PDE5抑制剂扎普司特(30 mg/kg)则无效。这些结果表明,PDE3和PDE4抑制剂均能够抑制致敏豚鼠抗原诱导的气道高反应性,并支持选择性PDE抑制剂在哮喘治疗中的潜在应用价值。